Riskpilot← Back to searchSign inGet full accessZerocyte Medical AB
ABActiveOrg 5594320631Myckelvägen 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20230 employees
Revenue 2025
SEK -1
-50% vs 2024
EBITDA margin
16552600.0%
+36% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -166K
+35% vs 2024
| Revenue | SEK -1 | -50% |
| EBITDA | SEK -166K | +36% |
| Net profit | SEK -166K | +35% |
| Total assets | SEK 158K | -51% |
| Equity | SEK 158K | -51% |
| Employees | 0 | — |
Legal name
Zerocyte Medical AB
Org number
5594320631
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 april 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget ska bedriva verksamhet inom forskning, utveckling och handel med medicintekniska produkter inklusive uthyrning och försäljning. Företaget ska bedriva konsultverksamhet inklusive klinisk tjänstgöring, arrangemang och deltagande vid medicinska konferenser och utbildningar.
Address
Myckelvägen 2
Email
andreas@zerocyte.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | −0 | −0 | −0 |
| Staff expenses | — | −10 | −0 |
| EBITDA | −243 | −257 | −166 |
| Depreciation & amort. | — | — | −0 |
| EBIT | −243 | −257 | −166 |
| Net financials | — | 0 | −0 |
| Profit before tax | −243 | −257 | −166 |
| Tax | — | — | — |
| Net profit | −243 | −257 | −166 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 282 | 324 | 158 |
| Equity | 282 | 324 | 158 |
| Long-term debt | — | — | — |
| Short-term debt | — | — | — |
| Total debt | — | — | — |
EBITDA margin
-16552600.0%
This company
15.8%
Market median
-104763391% vs market
20232025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20232025
Return on equity
-105.2%
This company
18.4%
Market median
-672% vs market
20232025
Net profit margin
-16594500.0%
This company
8.1%
Market median
-204870470% vs market
20232025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JC Chief Executive Officer | Chief Executive Officer | 2025 |
AO Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2023 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Zerocyte Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Josefin Christina Margareta Brännström | Chief Executive Officer | 0 companies |
| Andreas Olof Brännström | Deputy Chief Executive Officer | 0 companies |
| Carl Magnus Germund Ekvall | Board of Directors | 0 companies |
| Maria Ingeborg Sundblad Brännström | Deputy Board Member | 0 companies |